learn.connect & collaborate. 'Meet my Lab': Vaccine Research

This session has now ended. 

EURAXESS ASEAN presents ‘Meet my Lab’ - a virtual meeting point for researchers in ASEAN and across the world to learn from, to connect & to collaborate with each other.

This session will focus on vaccine research with speakers from Duke-NUS in Singapore and Institut Pasteur in France.

This 'Meet my Lab' session will take place on 22 September 2020 from 3.00pm to 4.00pm Singapore time (GMT+8).

meet_my_lab-vaccines_research-event_flyer.pdf

What is this?

‘Meet my Lab’ is a virtual meeting point profiling research teams working in the same field. The research teams will share their research work and present opportunities for collaboration. The focus is on interactivity - audience members can ask questions and engage with the presenter(s) and with each other.

Who can participate?

Meet my Lab’ is explicitly open to the world! We welcome researchers at all career stages and of all nationalities.

Participants MUST BE ACTIVELY INVOLVED IN VACCINE RESEARCH to join this session. 

Please note that we do NOT provide certificates of participation!

Participants should also have an interest in international research collaboration.

Each session will be limited to 80 participants.

Participation is free of charge. Seats will be allocated on a first come first served basis.

REGISTRATION

The topic - Vaccine Research

The creation of an efficacious, safe vaccine involves a large team of scientists, medical experts and industry partners from around the world and across multiple disciplines. This process typically requires 10 to 15 years of research and development before a vaccine can be made available to the public. During this ongoing COVID-19 pandemic, there is intense public interest in vaccine research as part of the global race to find a long-term solution to combat this outbreak.

In this ‘Meet My Lab’ session, we have invited vaccine researchers from Duke-NUS (Singapore) and Institut Pasteur (France) who work at the intersection of academic research and industry partnerships.

We will learn about their research progress on SARS-CoV-2 vaccine candidates, experience working with industry partners, and explore opportunities for collaboration.

Topics covered will include the following:

• Role of academic research in pandemic response

• Respective technology platforms that accelerate the development of safe, efficacious vaccines

• First-hand experience in establishing, managing industry, regulatory partnerships

• Challenges of vaccine development during a pandemic

Speakers:

Dr Ruklanthi (Rukie) de Alwis, Senior Research Fellow, Emerging Infectious Diseases Programme, Duke-NUS Medical School in Singapore

Dr Eugenia Ong, Research Fellow with the Emerging Infectious Diseases Programme at Duke-NUS Medical School in Singapore

Dr Phanramphoei Frantz AKA Dr. Jibby, postdoctoral researcher with the Innovation Lab Vaccines at Institut Pasteur in Paris, France / National Center for Genetic Engineering and Biotechnology (BIOTEC), NSTDA, Thailand

This session will be moderated by Dr Poh Weijie, Global Project Manager at Healint in Singapore.